BR Shetty

Dr Reddy’s to sell Hyderabad API unit to Therapiva

India’s leading drug maker Dr Reddy’s Laboratories has decided to sell its active pharmaceutical ingredients (APIs) manufacturing facility located in Hyderabad’s Jeedimetla in favour of Therapiva, an emerging generics pharmaceutical firm. Therapiva is a joint venture between Omnicare Drugs India, a wholly-owned subsidiary of Abu Dhabi based Neopharma LLC, and Laxai Life Sciences

Source: Economic Times